Technical Data
C5815-12D
c-Jun, phosphorylated (Ser73) Control Peptide
100ug
Molecular Biology Storage: -20°CShipping: Blue Ice
c-Jun is a member of the Jun Family containing c-Jun, JunB and JunD, and is a component of the transcription factor AP-1 (activator protein-1). AP-1 is composed of dimers of Fos, Jun and ATF family members and binds to and activates transcription at TRE/AP-1 elements (Reviewed in 1).Extracellular signals including growth factors, chemokines and stress activate AP-1-dependent transcription. The transcriptional activity of c-Jun is regulated by phosphorylation at Ser63 and Ser73 through SAPK/JNK (reviewed in 2). Knock-out studies in mice have shown that c-Jun is essential for embryogenesis (3), and subsequent studies have demonstrated roles for c-Jun in various tissues and developmental processes including axon regeneration (4), liver regeneration (5) and T cell development (6).AP-1 regulated genes exert diverse biological functions including cell proliferation, differentiation, and apoptosis, as well as transformation, invasion and metastasis, depending on cell type and context (7-9 ). Other target genes regulate survival as well as hypoxia and angiogenesis (8,10). c-Jun has emerged as a promising therapeutic target for cancer, vascular remodeling, acute inflammation, as well as rheumatoid arthritis (11-13).

Applications:
Suitable for use in Western Blotting, Immunohistochemistry. Other applications not tested.

Recommended Dilution:
Western immunoblotting, add 10ul of antibody and 10ul of blocking peptide to 10ml of antibody dilution buffer.
Immunohistochemistry, add 2ul of antibody and 10ul of blocking peptide to 0.088ml of buffer.

Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Form: Supplied as a liquid in 20 mM potassium phosphate (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 1 mg/ml BSA and 5% glycerol.
Specificity: This peptide is used to specifically block Phospho-c-Jun (Ser73) reactivity.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
1. Jochum, W. et al. (2001) Oncogene 20, 2401–12. 2. Davis, R.J. (2000) Cell 103, 239–52. 3. Hilberg, F. et al. (1993) Nature 365, 179–81. 4. Raivich, G. et al. (2004) Neuron 43, 57–67. 5. Behrens, A. et al. (2002) EMBO J 21, 1782–90. 6. Riera-Sans, L. and Behrens, A. (2007) J Immunol 178, 5690–700. 7. Leppδ, S. and Bohmann, D. (1999) Oncogene 18, 6158–62. 8. Shaulian, E. and Karin, M. (2002) Nat Cell Biol 4, E131–6. 9. Weiss, C. and Bohmann, D. (2004) Cell Cycle 3, 111–3. 10. Karamouzis, M.V. et al. (2007) Mol Cancer Res 5, 109–20. 11. Kim, S. and Iwao, H. (2003) J Pharmacol Sci 91, 177–81. 12. Weiss, C. and Bohmann, D. (2004) Cell Cycle 3, 111–3. 13. Dass, C.R. and Choong, P.F. (2008) Pharmazie 63,

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.